atezolizumab,xl092
exelixis,roche
['xl092', 'xl092 ', 'stellar-001', 'solid tumor', 'exelixis', '$exel']
$exel exelixis announces dose-escalation results from the phase 1 stellar-001 trial evaluating xl092 alone and in combination with an immune checkpoint inhibitor in patients with advanced solid tumors at esmo 2022 
Free Stock Market News are delayed 15 sec. Full features and live news available here: https://t.co/fWRacb3Vft